covid 19 News and Research

RSS

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

8 Nov 2022

Most echocardiography screenings for fetal congenital heart block fail to follow guidelines

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.

8 Nov 2022

Cancer drugs work better after vaccination with the Chinese Covid vaccine

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor.

8 Nov 2022

Does vitamin D reduce COVID-19 severity?

A new study examined published studies for a consistent association between vitamin D levels and coronavirus disease 2019 (COVID-19) severity.

8 Nov 2022

Hybrid immunity from vaccination and Omicron BA.1 or BA.5 breakthrough infections exhibits cross-reactive efficacy against BA.2.75

Researchers recently measured the neutralizing antibody titers against the wild-type strain of SARS-CoV-2 and the SARS-CoV-2 Omicron subvariants in healthcare workers fully vaccinated with three doses of the Comirnaty vaccine who experienced breakthrough Omicron infections.

8 Nov 2022

Italian study examines the experiences of expectant mothers during the COVID-19 pandemic

Researchers from Italy performed a qualitative study on the lived experiences of women who were pregnant during the COVID-19 pandemic to understand the adverse physical and mental health outcomes associated with experiencing pregnancy and childbirth during the pandemic-enforced restrictions.

8 Nov 2022

Study highlights the need for early and timely diagnosis of type 1 diabetes in children and adolescents

If children and young people have already developed metabolic imbalances (diabetic ketoacidosis) at the time of diagnosis of type 1 diabetes (T1D), this can result in complications such as extended stays in hospital, poorer long-term control of blood sugar levels, brain edema, or even a higher mortality rate.

8 Nov 2022

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.

8 Nov 2022

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

8 Nov 2022

Long-term administration of IV iron benefits adults with heart failure and iron deficiency

Long-term treatment with iron administered intravenously improved symptoms and reduced recurrent hospitalizations among people with heart failure and iron deficiency, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

U.S. COVID-19 vaccine safety surveillance results for the over 65s

In a recent study posted to the medRxiv* server, researchers conducted near real-time safety monitoring in the United States (US) elderly population for 14 safety outcomes weekly following the coronavirus disease 2019 (COVID-19) vaccination

7 Nov 2022

Researchers compare the risk of myocarditis between Pfizer and Moderna COVID-19 vaccines

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology.

7 Nov 2022

People living in the United States more likely to share COVID-19 misinformation online, study finds

People living in the United States are more than three times more likely to share misinformation and conspiracy theories about COVID-19 than people in four other English-speaking countries, including Canada, a Simon Fraser University study has found.

7 Nov 2022

Modeling predicts a declining trend in monkeypox cases globally and on a country-specific scale

In a recent study posted to the medRxiv* server, researchers at Georgia State University, USA, generated short-term forecasts of new monkeypox cases using an ensemble and subepidemic model.

7 Nov 2022

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

In a recent study published in the journal Annals of Diagnostic Pathology, researchers in the United States evaluated the impact of coronavirus disease 2019 (COVID-19) on central nervous system (CNS) damage in Alzheimer's disease (AD).

7 Nov 2022

New ‘guard rails’ could significantly bolster high quality care using telehealth

Today's telemedicine providers are only scratching the surface of what's possible in providing high-quality healthcare to people who need it most-;and especially to older adults who benefit greatly from its accessibility, according to researchers and clinical experts from West Health.

7 Nov 2022

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

In a recent study posted to the medRxiv* preprint server, researchers in Canada evaluated nirmatrelvir and ritonavir (Paxlovid) effectiveness against severe coronavirus disease 2019 (COVID-19) during the dominance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) and Omicron sub-VOCs in Canada.

7 Nov 2022

Vaccine confidence declined significantly since the start of the pandemic, study suggests

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic.

7 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

SARS-CoV-2 activates NLRP3 inflammasome

Researchers assessed the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation.

7 Nov 2022

covid 19 News and Research

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

Most echocardiography screenings for fetal congenital heart block fail to follow guidelines

Cancer drugs work better after vaccination with the Chinese Covid vaccine

Does vitamin D reduce COVID-19 severity?

Hybrid immunity from vaccination and Omicron BA.1 or BA.5 breakthrough infections exhibits cross-reactive efficacy against BA.2.75

Italian study examines the experiences of expectant mothers during the COVID-19 pandemic

Study highlights the need for early and timely diagnosis of type 1 diabetes in children and adolescents

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

Long-term administration of IV iron benefits adults with heart failure and iron deficiency

U.S. COVID-19 vaccine safety surveillance results for the over 65s

Researchers compare the risk of myocarditis between Pfizer and Moderna COVID-19 vaccines

People living in the United States more likely to share COVID-19 misinformation online, study finds

Modeling predicts a declining trend in monkeypox cases globally and on a country-specific scale

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

New ‘guard rails’ could significantly bolster high quality care using telehealth

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

Vaccine confidence declined significantly since the start of the pandemic, study suggests

Paxlovid antiviral therapy reduces risk of long COVID

SARS-CoV-2 activates NLRP3 inflammasome

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News